July 1, 2016

pedODAC Meeting – DIPG

Jonathan Agin, JD, Executive Director’s Public Comments before the Pediatric Subcommittee of the Oncologic Drugs Advisory Committee (pedODAC) Meeting. On June 29, 2016, I was one of […]